On both HRV14 (group A) and HRV399, the compound EMEB has definite anti-Rhinovirus activity (group B). The specific activity of Pirodavir used as a positive control is lower than that of Pirodavir, but since the cytotoxic activity of EMEB on human HeLa cells is more beneficial than that of...